325 related articles for article (PubMed ID: 8157970)
1. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
Wershil BK; Theodos CM; Galli SJ; Titus RG
J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
[TBL] [Abstract][Full Text] [Related]
2. Mast cell degranulation contributes to susceptibility to Leishmania major.
Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ
Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785
[TBL] [Abstract][Full Text] [Related]
3. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
[TBL] [Abstract][Full Text] [Related]
4. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
Morris L; Troutt AB; Handman E; Kelso A
J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
[TBL] [Abstract][Full Text] [Related]
5. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
6. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
8. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
[TBL] [Abstract][Full Text] [Related]
9. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy does not interfere with immune response to Leishmania major infection in mice.
Maioli TU; Carneiro CM; Assis FA; Faria AM
Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575
[TBL] [Abstract][Full Text] [Related]
11. Early IL-4 production does not predict susceptibility to Leishmania major.
Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
14. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection.
Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E
Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: recruitment of Gr-1+ cells into draining lymph nodes during infection is important for early IL-12 and IFN gamma production.
dos Santos MS; Vaz Cardoso LP; Nascimento GR; Lino Rde S; Dorta ML; de Oliveira MA; Ribeiro-Dias F
Exp Parasitol; 2008 Jul; 119(3):403-10. PubMed ID: 18501355
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
17. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.
Wershil BK; Mekori YA; Murakami T; Galli SJ
J Immunol; 1987 Oct; 139(8):2605-14. PubMed ID: 3655368
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
20. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]